美国食品和药物管理局批准非类固醇ZORYVE奶油用于轻度至中度湿疹的儿童. FDA approves non-steroidal ZORYVE cream for children 2–5 with mild to moderate eczema.

林业发展局批准了ZORYVE(氟化物)奶油0.05%,用于治疗2至5岁儿童的轻度至中度同位素性皮炎,提供一种非类固醇的、一次性的选择。 The FDA has approved ZORYVE (roflumilast) cream 0.05% for treating mild to moderate atopic dermatitis in children aged 2 to 5, offering a non-steroidal, once-daily option. 以第三阶段和长期试验数据为依据的核准表明,在几周内皮肤明显改善,56周后持续受益。 The approval, based on phase 3 and long-term trial data, shows significant skin improvement within weeks, with sustained benefits over 56 weeks. 它解决了年轻病人的主要治疗差距,减少了对长期类固醇的依赖。 It addresses a key treatment gap for young patients, reducing reliance on long-term steroids.